The timeline for FDA approval can vary widely, typically ranging from several months to several years. Factors influencing the timeline include the complexity of the treatment, the type of cancer, the quality of the clinical trial data, and the FDA's workload. Expedited programs like Fast Track, Breakthrough Therapy, and Priority Review can accelerate the process for promising treatments addressing unmet medical needs.
